About MCRC

This author has not yet filled in any details.
So far MCRC has created 129 blog entries.
  • allen & gettisen

The Greater Boston Convention & Visitors Bureau Partners with Allen & Gerritsen to Create Homegrown Tourism Video

Allen & Gerritsen (A&G) and The Greater Boston Convention & Visitors Bureau (GBCVB) – the not-for-profit organization promoting tourism and visitation to Boston, Cambridge and the surrounding metropolitan area – premiered a video featuring the sights and sounds of the city to remind local residents why Boston is and always will be home. Click here to read full press release.

By |2020-06-15T19:42:51+00:00June 15th, 2020|News|Comments Off on The Greater Boston Convention & Visitors Bureau Partners with Allen & Gerritsen to Create Homegrown Tourism Video
  • PTG

Packaging Technology Group (PTG) Expands National Footprint with Opening of New Louisville, Kentucky Location

June 9, 2020 – Greater Boston, MA and Louisville, KY- Packaging Technology Group, Inc., (PTG), a leading provider of thermalpackaging solutions for the biopharmaceutical and life sciences sector,announced today the opening of a new location in Louisville, Kentucky.  Thenewly constructed facility, called PTG Kentucky, is located at 1001 GlengarryDrive, Fairdale, KY. Click here to read full press release.

By |2020-06-09T19:47:56+00:00June 9th, 2020|News|Comments Off on Packaging Technology Group (PTG) Expands National Footprint with Opening of New Louisville, Kentucky Location
  • allen & gettisen

Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home

Allen & Gerritsen (A&G) and Safety 1st, a leading provider of child safety products, today unveiled “Signs of the Times,” a creative campaign rooted in empathy and humor that has refreshed the brand’s iconic “Baby on Board” sign for parents working from home during the novel coronavirus (COVID-19) pandemic. Created by parents, for parents, the campaign assets include both video and static backgrounds for virtual meetings, as well as Instagram stickers and GIFs. Click here to read full press release.

By |2020-05-13T19:39:20+00:00May 13th, 2020|News|Comments Off on Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home
  • Vero

Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine

Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide.  Click here to read full press release.

By |2020-05-06T22:37:03+00:00May 6th, 2020|News|Comments Off on Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
  • Vero

Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals

VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted with complications of COVID with GENOSYL® DS, the first and only FDA-approved tankless system for the delivery of inhaled nitric oxide.  Click here to read full press release.

By |2020-04-08T22:31:45+00:00April 8th, 2020|News|Comments Off on Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
  • Vero

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1.  Click here for full press release

By |2020-03-26T23:45:55+00:00March 26th, 2020|News|Comments Off on FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Vero

VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide.  Click here to read full press release

By |2020-03-24T23:52:33+00:00March 24th, 2020|News|Comments Off on VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Segue

Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement

LOWELL January 14, 2020 -- Segue Manufacturing Services LLC has been selected for the 2020 Best of Lowell Award in the Electronic Parts Supplier category by the Lowell Award Program.  Click here to read press release.

By |2020-01-14T22:40:36+00:00January 14th, 2020|News|Comments Off on Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement
Go to Top